The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer‐specific survival
暂无分享,去创建一个
A. Mes-Masson | F. Saad | M. Latour | A. Bergeron | M. Ladouceur | R. Albadine | Andrée-Anne Grosset | D. Trudel | Y. Fradet | H. Hovington | N. Benzerdjeb | B. Mansoori | V. Trinh | J. Sirois
[1] Esther I Verhoef,et al. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy , 2016, Modern Pathology.
[2] F. Montorsi,et al. Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades , 2016, BJU international.
[3] D. Berney,et al. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists , 2016, Journal of Clinical Pathology.
[4] Naoto Sassa,et al. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation , 2016, Modern Pathology.
[5] B. Delahunt,et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.
[6] L. Kunju,et al. Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices. , 2015, Archives of pathology & laboratory medicine.
[7] Ewout W Steyerberg,et al. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer , 2015, Modern Pathology.
[8] C. Sweeney,et al. Management of Metastatic Hormone-Sensitive Prostate Cancer , 2015, Current Urology Reports.
[9] Jiyan Liu,et al. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? , 2015, The Prostate.
[10] N. Willich,et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. , 2014, European urology.
[11] T. H. van der Kwast,et al. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. , 2014, European journal of cancer.
[12] T. Tsuzuki,et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens , 2014, The Prostate.
[13] Ming Zhou,et al. Intraductal Carcinoma of Prostate: A Comprehensive and Concise Review , 2013, Korean journal of pathology.
[14] T. H. van der Kwast,et al. Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer? , 2013, The Prostate.
[15] L. Collette,et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.
[16] R. Shah,et al. Atypical Cribriform Lesions of the Prostate: Clinical Significance, Differential Diagnosis and Current Concept of Intraductal Carcinoma of the Prostate , 2012, Advances in anatomic pathology.
[17] T. H. van der Kwast,et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. , 2012, European journal of cancer.
[18] A. Partin,et al. Evolution of the clinical presentation of men undergoing radical prostatectomy for high‐risk prostate cancer , 2012, BJU international.
[19] C. Magi-Galluzzi,et al. Intraductal carcinoma of the prostate. , 2012, Archives of pathology & laboratory medicine.
[20] J. Epstein,et al. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. , 2010, The Journal of urology.
[21] A. Renshaw,et al. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. , 2009, Archives of pathology & laboratory medicine.
[22] E. Messing,et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.
[23] A. Evans,et al. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications , 2009, Journal of Clinical Pathology.
[24] Christopher Otis,et al. Recommendations for the reporting of prostate carcinoma. , 2007, Virchows Archiv : an international journal of pathology.
[25] Jonathan I. Epstein,et al. Recommendations for the reporting of prostate carcinoma , 2007, Virchows Archiv.
[26] J. Epstein,et al. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance , 2006, Modern Pathology.
[27] P. Scardino,et al. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. , 1998, Human pathology.
[28] M. Rubin,et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. , 1998, The American journal of surgical pathology.